Patients’ Preferences for Androgen Deprivation Therapy in the Treatment of Intermediate-Risk Prostate Cancer

Background. For men with intermediate-risk prostate cancer (IRPC), adding short-term androgen deprivation therapy (ADT) to external beam radiation therapy (EBRT) has shown efficacy, but men are often reluctant to accept it because of its impact on quality of life. Methods. We conducted time tradeoff...

Descripción completa

Detalles Bibliográficos
Autores principales: De, Brian, Lowenstein, Lisa M., Corrigan, Kelsey L., Andring, Lauren M., Kuban, Deborah A., Cantor, Scott B., Volk, Robert J., Hoffman, Karen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669695/
https://www.ncbi.nlm.nih.gov/pubmed/36405544
http://dx.doi.org/10.1177/23814683221137752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669695/
https://www.ncbi.nlm.nih.gov/pubmed/36405544
http://dx.doi.org/10.1177/23814683221137752

Ejemplares similares